Your browser doesn't support javascript.
loading
Impact of pre-adapted HIV transmission.
Carlson, Jonathan M; Du, Victor Y; Pfeifer, Nico; Bansal, Anju; Tan, Vincent Y F; Power, Karen; Brumme, Chanson J; Kreimer, Anat; DeZiel, Charles E; Fusi, Nicolo; Schaefer, Malinda; Brockman, Mark A; Gilmour, Jill; Price, Matt A; Kilembe, William; Haubrich, Richard; John, Mina; Mallal, Simon; Shapiro, Roger; Frater, John; Harrigan, P Richard; Ndung'u, Thumbi; Allen, Susan; Heckerman, David; Sidney, John; Allen, Todd M; Goulder, Philip J R; Brumme, Zabrina L; Hunter, Eric; Goepfert, Paul A.
Afiliação
  • Carlson JM; Microsoft Research, Redmond, Washington, USA.
  • Du VY; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Pfeifer N; Microsoft Research, Redmond, Washington, USA.
  • Bansal A; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Tan VY; Microsoft Research, Redmond, Washington, USA.
  • Power K; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA.
  • Brumme CJ; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
  • Kreimer A; Microsoft Research, Redmond, Washington, USA.
  • DeZiel CE; Microsoft Research, Redmond, Washington, USA.
  • Fusi N; Microsoft Research, Redmond, Washington, USA.
  • Schaefer M; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
  • Brockman MA; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
  • Gilmour J; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
  • Price MA; International AIDS Vaccine Initiative, New York, New York, USA.
  • Kilembe W; Imperial College of Science, Technology and Medicine, London, UK.
  • Haubrich R; International AIDS Vaccine Initiative, New York, New York, USA.
  • John M; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
  • Mallal S; Rwanda-Zambia HIV Research Group, Zambia-Emory HIV Research Project, Lusaka, Zambia.
  • Shapiro R; Gilead Sciences, Foster City, California, USA.
  • Frater J; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia.
  • Harrigan PR; Department of Clinical Immunology, Royal Perth Hospital, Perth, Western Australia, Australia.
  • Ndung'u T; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia.
  • Allen S; Center for Translational Immunology and Infectious Diseases, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Heckerman D; Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.
  • Sidney J; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
  • Allen TM; National Institute of Health Research, Oxford Biomedical Research Centre, Oxford, UK.
  • Goulder PJ; Institute for Emerging Infections, Oxford Martin School, University of Oxford, Oxford, UK.
  • Brumme ZL; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
  • Hunter E; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Goepfert PA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA.
Nat Med ; 22(6): 606-13, 2016 06.
Article em En | MEDLINE | ID: mdl-27183217
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adaptação Fisiológica / Antígenos de Histocompatibilidade Classe I / Infecções por HIV / HIV-1 / Linfócitos T CD8-Positivos / Evasão da Resposta Imune Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adaptação Fisiológica / Antígenos de Histocompatibilidade Classe I / Infecções por HIV / HIV-1 / Linfócitos T CD8-Positivos / Evasão da Resposta Imune Idioma: En Ano de publicação: 2016 Tipo de documento: Article